Cargando…
抗体偶联药物在晚期非小细胞肺癌中的研究进展
Lung cancer is one of the malignant tumors with the highest morbidity and mortality in the world. Non-small cell lung cancer (NSCLC) is one of the most important pathological types of lung cancer. The prognosis of advanced NSCLC is poor and medical treatment is still the main treatment option. Antib...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976206/ https://www.ncbi.nlm.nih.gov/pubmed/35340165 http://dx.doi.org/10.3779/j.issn.1009-3419.2022.102.01 |